Latest Breaking News On - Ventricular septal defect occluder - Page 1 : comparemela.com

SHENZHEN, China, March 29, 2023 /PRNewswire/ LifeTech Scientific Corporation (the "Company" or "Lifetech"), a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, today announced its 2022 annual results. During the year ended 31 December 2022, Lifetech achieved a revenue of approximately RMB1,097.3 million, increased by 18.6% year on year. The.

United statesAortic branch stent graft systemAortic arch branch stent graft systemAdult congenital heart disease centerLifetech scientific corporationMinistry of foodLifetech scientific corporation stock codeNational medical products administrationDrug administration for compassionateShowa university hospitalLifetech scientific corporation the company orLeft atrial appendageCongenital heart diseasesVena cava filter systemBalloon dilatation catheterStent graft system